News of Note—Bavarian Nordic, FluGen and more

newspapers
(Pixabay)

Here is some other vaccine news of note for the week:

> Bavarian Nordic shipped Imvanex smallpox vaccine doses to England after authorities there recorded monkeypox cases. Release

> The National Institutes of Health is supporting phase 1 testing of a broadly protective flu vaccine developed by FluGen. Release

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> Sinovac reports that the U.S. Department of Justice has closed an investigation into the company. Release

> In a preclinical study, an experimental H3N2 flu DNA vaccine from Inovio elicited antibody responses and protected against a heterologous lethal challenge. Release

Suggested Articles

After countless headlines from a Dengvaxia safety scandal in the Philippines, officials are now considering using the Sanofi vaccine again.

Merck's oncology superstar Keytruda has been stealing the spotlight, but in vaccines, the drugmaker has growth figures to tout.

Experts are pushing for the introduction of J&J's vaccine in the response to the Ebola outbreak in the Democratic Republic of Congo.